Global Health Current Valuation vs. Price To Sales
| MEDANTA Stock | 1,125 8.80 0.78% |
For Global Health profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Global Health to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Global Health Limited utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Global Health's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Global Health Limited over time as well as its relative position and ranking within its peers.
Global |
Global Health Limited Price To Sales vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Global Health's current stock value. Our valuation model uses many indicators to compare Global Health value to that of its competitors to determine the firm's financial worth. Global Health Limited is rated top company in current valuation category among its peers. It also is considered to be number one stock in price to sales category among its peers . The ratio of Current Valuation to Price To Sales for Global Health Limited is about 33,334,500,466 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Global Health by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Global Health's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Global Current Valuation vs. Competition
Global Health Limited is rated top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is now estimated at about 44.31 Trillion. Global Health maintains roughly 301.18 Billion in current valuation contributing less than 1% to equities under Health Care industry.
Global Price To Sales vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Global Health |
| = | 301.18 B |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Global Health |
| = | 9.04 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Global Price To Sales Comparison
Global Health is currently under evaluation in price to sales category among its peers.
Global Health Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Global Health, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Global Health will eventually generate negative long term returns. The profitability progress is the general direction of Global Health's change in net profit over the period of time. It can combine multiple indicators of Global Health, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 196.5 M | 374.2 M | |
| Operating Income | 11.7 B | 12.3 B | |
| Income Before Tax | 6.3 B | 6.6 B | |
| Total Other Income Expense Net | -5.4 B | -5.2 B | |
| Net Income | 4.8 B | 5 B | |
| Income Tax Expense | 1.5 B | 1.6 B | |
| Net Interest Income | -701.3 M | -736.3 M | |
| Interest Income | 150.5 M | 144.3 M | |
| Net Income From Continuing Ops | 3.7 B | 3.9 B |
Global Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Global Health. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Global Health position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Global Health's important profitability drivers and their relationship over time.
Use Global Health in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Global Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Global Health will appreciate offsetting losses from the drop in the long position's value.Global Health Pair Trading
Global Health Limited Pair Trading Analysis
The ability to find closely correlated positions to Global Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Global Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Global Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Global Health Limited to buy it.
The correlation of Global Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Global Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Global Health Limited moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Global Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Global Health position
In addition to having Global Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Target Outcome ETFs Thematic Idea Now
Target Outcome ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Target Outcome ETFs theme has 92 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Target Outcome ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Global Stock
To fully project Global Health's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Global Health Limited at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Global Health's income statement, its balance sheet, and the statement of cash flows.